S 6925

  • New York Senate Bill
  • 2025 Regular Session
  • Introduced in Senate
  • Senate
  • Assembly
  • Governor

Relates to capping cost sharing for antiviral COVID-19 therapeutics

Abstract

Requires insurance companies, medical expense indemnity corporations, hospital service corporations, health service corporations and medical assistance programs to provide coverage for prescribed antiviral therapeutics approved by the food and drug administration for the treatment of COVID-19 at no cost to the patient.

Bill Sponsors (1)

Votes


No votes to display

Actions


Mar 27, 2025

Senate

REFERRED TO INSURANCE

  • Referral-Committee
INSURANCE

Bill Text

Bill Text Versions Format
S6925 PDF HTML

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the New York Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.